Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

The Use Of Antidepressants And Therapeutic Drug Monitoring By General Practitioners And Psychiatrists: Findings From A Questionnaire Survey In Two Swedish Areas.

G. Isacsson, U. Bergman, D. Wasserman, I. Redfors, F. Sjöqvist
Published 1996 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
We wished to assess general practitioners' and psychiatrists' sensitivity and specificity in the diagnosis of depression, rationale for drug of choice, average and range of prescribed daily doses of antidepressants, and use of therapeutic drug monitoring (TDM). A questionnaire survey was given to 264 psychiatrists and general practitioners (GPs) in one urban area of Stockholm and the rural county of Jamtland, Sweden. The response rate was 86% (n = 228). The survey was validated against independent studies of actual prescription rates. One of eight physicians presented with a hypothetical case history of major depression appeared unwilling to use antidepressants. Two-thirds of the GPs and one-fourth of the psychiatrists usually prescribed doses that were too low. Many doctors never prescribed doses higher than 150 mg/day of common tricyclic antidepressants, although many patients clearly need higher doses. The choice of drug was based mostly on the therapeutic tradition and seldom on considerations of scientific evidence. The few physicians who utilized TDM (plasma concentrations) for dosing prescribed a more flexible dosage schedule and higher average doses as well as higher maximal doses. Interestingly, there were no significant differences in dosing between GPs and psychiatrists in this group, while striking differences were found in the whole study group, with GPs prescribing much smaller doses. Regular use of TDM as a means for individualizing the dose regimen of antidepressants should be encouraged, as well as continuous education of general practitioners in the diagnosis and treatment of depression.



This paper is referenced by
10.1136/qhc.11.3.214
Guideline adherence rates and interprofessional variation in a vignette study of depression
H. Tiemeier (2002)
10.12968/PNUR.2007.18.3.23285
Barriers to insulin starts for type 2 diabetes
L. M. Wong (2007)
10.1007/978-3-662-50347-8_10
Therapeutisches Drug Monitoring
Christoph Hiemke (2017)
10.1016/0165-0327(96)00050-X
Epidemiological data suggest antidepressants reduce suicide risk among depressives.
G. Isacsson (1996)
10.1185/03007990802278644
Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus
M. Peyrot (2008)
10.1111/j.1600-0447.2006.00793.x
Antidepressants: general practitioners’ opinions and clinical practice
S. Rambelomanana (2006)
10.1007/s002280050275
Changes in the pattern of antidepressant use upon the introduction of the new antidepressants: a prescription database study
J.-U. Rosholm (1997)
10.1345/aph.19079
Factors Affecting Prescribing of the Newer Antidepressants
G. Garrison (2000)
10.1034/j.1600-0447.2001.103003238.x
Antidepressants and suicide prevention in Hungary
Z. Rihmer (2001)
10.1016/B978-0-444-64066-6.00011-3
Therapeutic drug monitoring of antidepressant and antipsychotic drugs
P. Mitchell (2004)
10.1002/PDS.1410
Correlates of low‐dosage treatment with antidepressants by psychiatrists and general practitioners
K. Schotte (2007)
10.2337/DIACARE.28.11.2673
Resistance to Insulin Therapy Among Patients and Providers Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study
M. Peyrot (2005)
10.1111/J.1365-2648.2005.03527.X
Nurse prescribers: who are they and how do they perceive their role?
E. Bradley (2005)
10.1097/00019442-200108000-00010
Treatment outcome in suicidal vs. non-suicidal elderly patients.
K. Szántó (2001)
10.1111/J.1365-2702.2006.01378.X
Neuropharmacology and mental health nurse prescribers.
David Skingsley (2006)
10.1034/j.1600-0447.2003.00088.x
Antidepressants: psychiatrists' opinions and clinical practice
F. Depont (2003)
10.2337/DIACARE.29.04.06.DC05-0053
Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study.
M. Peyrot (2005)
10.1046/J.1365-2125.2000.00174.X
Therapeutic drug monitoring of psychotropic medications.
P. Mitchell (2001)
10.1016/S0165-0327(98)00083-4
Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database.
G. Isacsson (1999)
10.2174/1567201812666151029100909
Consensus Guideline Based Therapeutic Drug Monitoring (TDM) in Psychiatry and Neurology.
C. Hiemke (2016)
10.1097/FTD.0000000000000167
Prevalence of Therapeutic Drug Monitoring for Antidepressants and Antipsychotics in Stockholm, Sweden: A Longitudinal Analysis
S. Wallerstedt (2015)
10.1055/s-0031-1286281
Therapeutic drug monitoring in Italian psychiatry.
A. Conca (2011)
Insulin Myths and Impact of Round-Tree Group Education Programme on Acceptance of Insulin in Persons with Diabetes: A Study from the Himalayas.
Jatinter Mokta (2017)
10.31237/osf.io/7wue6
Depression and antidepressants in Australia and beyond - a critical public health analysis
M. Raven (2012)
10.1080/08039480600583852
Improved detection and pharmacotherapy of major depression from 1989 to 2001 in psychiatric outpatient care in Finland
M. Sorvaniemi (2006)
Semantic Scholar Logo Some data provided by SemanticScholar